NL6915958A - - Google Patents
Info
- Publication number
- NL6915958A NL6915958A NL6915958A NL6915958A NL6915958A NL 6915958 A NL6915958 A NL 6915958A NL 6915958 A NL6915958 A NL 6915958A NL 6915958 A NL6915958 A NL 6915958A NL 6915958 A NL6915958 A NL 6915958A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77747968A | 1968-11-20 | 1968-11-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL6915958A true NL6915958A (pt) | 1970-05-22 |
Family
ID=25110373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL6915958A NL6915958A (pt) | 1968-11-20 | 1969-10-22 |
Country Status (8)
Country | Link |
---|---|
US (1) | US3549633A (pt) |
AT (1) | AT291250B (pt) |
BR (1) | BR6914169D0 (pt) |
CH (1) | CH518957A (pt) |
ES (1) | ES373698A1 (pt) |
FR (1) | FR2070653A1 (pt) |
GB (1) | GB1242625A (pt) |
NL (1) | NL6915958A (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053577A (en) * | 1972-02-18 | 1977-10-11 | Tioxide Group Limited | Process for the gaseous phase production of metal oxide particles |
GR74944B (pt) * | 1980-07-02 | 1984-07-12 | Merck & Co Inc | |
NZ710405A (en) * | 2010-11-16 | 2017-04-28 | Acetylon Pharmaceuticals Inc | Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
WO2015054099A1 (en) | 2013-10-08 | 2015-04-16 | Acetylon Pharmaceuticals, Inc. | Combinations of histone deacetylase inhibitors and either her2 inhibitors or pi3k inhibitors |
EP3055299B1 (en) | 2013-10-10 | 2021-01-06 | Acetylon Pharmaceuticals, Inc. | Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors |
US10660890B2 (en) | 2013-10-24 | 2020-05-26 | National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Nih Division Of Extramural Inventions And Technology Resources (Deitr) | Treatment of polycystic diseases with an HDAC6 inhibitor |
US9949972B2 (en) | 2013-12-03 | 2018-04-24 | Acetylon Pharmaceuticals, Inc | Combinations of histone deacetylase inhibitors and immunomodulatory drugs |
US9464073B2 (en) | 2014-02-26 | 2016-10-11 | Acetylon Pharmaceuticals, Inc. | Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors |
CN107205988A (zh) | 2014-07-07 | 2017-09-26 | 埃斯泰隆制药公司 | 利用组蛋白脱乙酰酶抑制剂治疗白血病 |
WO2016087950A1 (en) | 2014-12-05 | 2016-06-09 | University of Modena and Reggio Emilia | Combinations of histone deacetylase inhibitors and bendamustine for use in the treatment of lymphoma |
US10272084B2 (en) | 2015-06-01 | 2019-04-30 | Regenacy Pharmaceuticals, Llc | Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy |
WO2017184774A1 (en) | 2016-04-19 | 2017-10-26 | Acetylon Pharmaceuticals, Inc. | Hdac inhibitors, alone or in combination with btk inhibitors, for treating chronic lymphocytic leukemia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE651729A (pt) * | 1962-10-30 | 1965-02-12 | ||
US3361748A (en) * | 1965-11-22 | 1968-01-02 | Merck & Co Inc | Process for the preparation of pteridinones |
-
1968
- 1968-11-20 US US777479A patent/US3549633A/en not_active Expired - Lifetime
-
1969
- 1969-10-22 NL NL6915958A patent/NL6915958A/xx unknown
- 1969-11-13 BR BR214169/69A patent/BR6914169D0/pt unknown
- 1969-11-13 CH CH1690669A patent/CH518957A/de not_active IP Right Cessation
- 1969-11-17 GB GB56182/69A patent/GB1242625A/en not_active Expired
- 1969-11-19 ES ES373698A patent/ES373698A1/es not_active Expired
- 1969-11-19 AT AT1082669A patent/AT291250B/de not_active IP Right Cessation
- 1969-11-20 FR FR6939940A patent/FR2070653A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CH518957A (de) | 1972-02-15 |
GB1242625A (en) | 1971-08-11 |
ES373698A1 (es) | 1972-02-01 |
FR2070653A1 (pt) | 1971-09-17 |
AT291250B (de) | 1971-07-12 |
US3549633A (en) | 1970-12-22 |
BR6914169D0 (pt) | 1973-02-22 |